Apogee Therapeutics, Inc. (APGE)
NASDAQ:APGE
US Market
Holding APGE?
Track your performance easily

Apogee Therapeutics, Inc. (APGE) Ownership - Who Owns Apogee Therapeutics, Inc.?

106 Followers

Apogee Therapeutics, Inc. (APGE) Ownership Overview

12.69%28.01%2.41%10.99%45.89%
12.69% Insiders
2.41% Other Institutional Investors
10.99% ETFs
45.89% Public Companies and
Individual Investors
The ownership structure of Apogee Therapeutics, Inc. (APGE) stock is a mix of institutional, retail, and individual investors. Approximately 41.42% of the company’s stock is owned by Institutional Investors, 12.69% is owned by Insiders, and 45.89% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 23, 2024
xxxxxxxxxxxxx
$289560

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$3148000
Jun 30, 2024
xxxxxxxxxxxxx
$5803023
Jun 30, 2024
xxxxxxxxxxxxx
$29361356
Jun 30, 2024
xxxxxxxxxxxxx
$77199309

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,308,726Institution5.13%141,109,333
2,150,979Insider4.78%131,467,836
2,117,870Institution4.71%129,444,214
2,105,636Institution4.68%128,696,472
2,048,647Institution4.55%125,213,305
1,975,470Institution4.39%120,740,726
1,961,863Institution4.36%119,909,067
1,787,356Institution3.97%109,243,199
1,750,000Insider3.89%106,960,000
1,573,698Institution3.50%96,184,422

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,308,726Institution5.13%141,109,333
1,573,698Institution3.50%96,184,422
1,569,000Institution3.49%95,897,280
770,551Institution1.71%47,096,077
596,239Institution1.33%36,442,128
555,743Institution1.24%33,967,012
530,354Institution1.18%32,415,236
503,423Institution1.12%30,769,214
444,732Institution0.99%27,182,020
416,637Institution0.93%25,464,853

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,202,299Institution2.67%70,623,043
1,032,623Institution2.29%63,113,918
615,272Institution1.37%35,716,540
483,464Institution1.07%28,398,675
341,984Institution0.76%20,902,062
260,758Institution0.58%15,937,529
173,534Institution0.39%10,193,387
157,039Institution0.35%9,116,114
70,740Institution0.16%4,323,629
64,342Institution0.14%3,779,449

FAQ

Who Owns Apogee Therapeutics, Inc. (APGE)?
According to the latest TipRanks data, approximately 2.41% of the company's stock is held by institutional investors, 12.69% is held by insiders, and 45.89% is held by retail investors.
    What percentage of Apogee Therapeutics, Inc. (APGE) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 2.41% of Apogee Therapeutics, Inc. (APGE) stock is held by institutional investors.
      What percentage of Apogee Therapeutics, Inc. (APGE) stock is held by retail investors?
      According to the latest TipRanks data, approximately 45.89% of Apogee Therapeutics, Inc. (APGE) stock is held by retail investors.
        Who owns the most shares of Apogee Therapeutics, Inc. (APGE)?
        Fidelity Mt. Vernon Street Trust owns the most shares of Apogee Therapeutics, Inc. (APGE).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis